These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1768559)
41. The pharmacokinetics and effects of prochlorperazine in elderly female volunteers. Isah AO; Rawlins MD; Bateman DN Age Ageing; 1992 Jan; 21(1):27-31. PubMed ID: 1553856 [TBL] [Abstract][Full Text] [Related]
42. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs. Boothe DM; Perkins J J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of azapropazone following single oral and intravenous doses. Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795 [TBL] [Abstract][Full Text] [Related]
44. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route. Finn A; Collins J; Voyksner R; Lindley C J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713 [TBL] [Abstract][Full Text] [Related]
45. Excretion of S35 following administration of s35-prochlorperazine to rats subjected to experimental stress. PHILLIPS BM; MIYA TS Proc Soc Exp Biol Med; 1962 Mar; 109():576-7. PubMed ID: 14486225 [No Abstract] [Full Text] [Related]
46. PERPHENAZINE (TRILAFON) METABOLISM IN PSYCHOTIC PATIENTS. HUANG CL; KURLAND AA Arch Gen Psychiatry; 1964 Jun; 10():639-46. PubMed ID: 14159263 [No Abstract] [Full Text] [Related]
47. The psychopharmacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine, promethazine, trifluoperazine, and perphenazine in normal males. II. Results and discussion. DIMASCIO A; HAVENS LL; KLERMAN GL J Nerv Ment Dis; 1963 Feb; 136():168-86. PubMed ID: 14027913 [No Abstract] [Full Text] [Related]
50. A simple and sensitive H.P.L.C. method for the assay of prochlorperazine in plasma. Sankey MG; Holt JE; Kaye CM Br J Clin Pharmacol; 1982 Apr; 13(4):578-80. PubMed ID: 7066176 [No Abstract] [Full Text] [Related]
51. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. Richelson E J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602 [TBL] [Abstract][Full Text] [Related]
52. The effects of astemizole on histamine-induced weal and flare. Bateman DN; Chapman PH; Rawlins MD Eur J Clin Pharmacol; 1983; 25(4):547-51. PubMed ID: 6140168 [TBL] [Abstract][Full Text] [Related]
53. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Sakalis G; Curry SH; Mould GP; Lader MH Clin Pharmacol Ther; 1972; 13(6):931-46. PubMed ID: 5081606 [No Abstract] [Full Text] [Related]
54. Prochlorperazine--a review of the literature since 1956. Lapierre J; Amin M; Hattangadi S Can Psychiatr Assoc J; 1969 Jun; 14(3):267-74. PubMed ID: 4890978 [No Abstract] [Full Text] [Related]
55. Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa. Turkington RW Arch Intern Med; 1972 Sep; 130(3):349-54. PubMed ID: 4560178 [No Abstract] [Full Text] [Related]
56. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers. Taylor WB; Bateman DN Br J Clin Pharmacol; 1987 Feb; 23(2):137-42. PubMed ID: 3828192 [TBL] [Abstract][Full Text] [Related]
57. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Bateman DN; Rawlins MD; Simpson JM Q J Med; 1986 Jun; 59(230):549-56. PubMed ID: 3749448 [TBL] [Abstract][Full Text] [Related]